Physician
Northeast Wyoming Pediatric Associates, P.C.
Northeast Wyoming Pediatric Associates, P.C. was paid $3.19M by Medicaid between Jan 2018 and Nov 2024, across 48 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoNORTHEAST WYOMING PEDIATRIC ASSOCIATES, P.C.
SHERIDAN, WY 82801
SHERIDAN, WY 82801
33aNPI1114998259assigned 01/27/2006
33bProvider typePediatrics Physician
28Total paid$3.19M
24GClaims73,328
24DCodes billed48
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Wyoming
Rank by total paid#2 of 27
Median peer was paid$113K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,664 | $523K | |
| 2019 | 9,733 | $514K | |
| 2020 | 8,604 | $431K | |
| 2021 | 11,642 | $447K | |
| 2022 | 11,924 | $474K | |
| 2023 | 11,616 | $444K | |
| 2024incomplete | 9,145 | $354K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 14,135 | 12,518 | $1.24M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 13,167 | 11,651 | $764K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 10.0% | 7,887 | 7,415 | $318K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.1% | 3,006 | 2,792 | $227K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.9% | 2,633 | 2,543 | $221K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 1,164 | 1,135 | $96K |
| 87428 | 2.2% | 1,516 | 1,456 | $70K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 551 | 539 | $52K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 1,788 | 1,745 | $42K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 764 | 602 | $27K |
| 96127 | <1% | 3,890 | 3,711 | $23K | |
| 94760 | <1% | 8,171 | 7,396 | $21K |
36 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,489 | $20K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 946 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 698 | $12K |
| 99051 | <1% | 1,004 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 272 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 132 | $5K |
| 87807 | <1% | 354 | $5K | |
| 99188 | <1% | 95 | $3K | |
| 99336 | <1% | 18 | $2K | |
| 90670 | <1% | 1,025 | $2K | |
| 90686 | <1% | 2,352 | $2K | |
| 0071A | <1% | 39 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 72 | $966.17 |
| 0072A | <1% | 23 | $920.00 | |
| 86328 | <1% | 16 | $720.89 | |
| 90723 | <1% | 506 | $573.28 | |
| 90680 | <1% | 549 | $399.76 | |
| 90461 | <1% | 2,597 | $197.05 | |
| 99173 | <1% | 587 | $156.93 | |
| 90697 | <1% | 55 | $139.82 | |
| 90734 | <1% | 81 | $113.32 | |
| 90656 | <1% | 150 | $103.68 | |
| 81000 | <1% | 32 | $96.30 | |
| 81002 | <1% | 41 | $91.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 72 | $88.75 |
| 90685 | <1% | 146 | $64.33 | |
| 99072 | <1% | 63 | $6.32 | |
| 90633 | <1% | 106 | $0.67 | |
| 90649 | <1% | 61 | $0.35 | |
| 90648 | <1% | 107 | $0.17 | |
| 90715 | <1% | 13 | $0.11 | |
| 90677 | 0% | 269 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 55 | $0.00 |
| 91307 | 0% | 91 | $0.00 | |
| 90647 | 0% | 12 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 528 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOSS, SUZANNE (PRESIDENT)